The Department of Veterans Affairs (VA) Pharmacy Benefits Management Services and the Institute for Clinical and Economic Review (ICER) recently announced a collaboration in which the VA will use the ICER’s drug assessments as part of its formulary development
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/09/18/caution-warranted-as-va-incorporates-icer-value-assessments-into-formulary-management-process/
Posted
Sep 18 2017, 06:00 AM
by
Health Affairs BlogHealth Affairs Blog
Filed under: Population Health, Payment Policy, Insurance and Coverage, Costs and Spending, Veterans' Health Care, quality of care, drug pricing, Drugs and Medical Innovation, Department of Veterans Affairs, pharmaceuticals, Institute for Clinical and Economic Review